RSV, or Respiratory Syncytial Virus, is a common viral infection that affects both children and adults. RSV season usually occurs in the winter months and can cause inflammation of the small airways in the lung leading to breathing difficulties. RSV can be particularly dangerous for young children with weakened immune systems and those younger than 6 months of age are at high risk for life-threatening RSV infections. There are several treatments available for RSV which range from preventative measures such as staying hydrated and avoiding contact with others during RSV season to more aggressive treatments such as mechanical ventilation or intravenous (IV) fluids if necessary. In this blog we will discuss some of the most effective treatments for RSV, including ways to prevent it from occurring in the first place.

Are there any approved vaccines for RSV?

While RSV has been around for a long time, there aren’t any approved vaccines that are available for prevention purposes. However, a vaccine is finally in the process of being produced. Researchers have been working for decades to create an RSV vaccine that would protect vulnerable populations from RSV-related diseases. Recently, scientists have made great strides towards this goal with the development of a RSV vaccine based on RSV particles. This protein-based vaccine is designed to induce a protective immune response against RSV by targeting its surface protein called F protein. Currently, clinical trials are underway to test the safety and efficacy of this promising new RSV vaccine. Pfizer is currently conducting trials on a RSV vaccine that could potentially help to prevent the virus from spreading. The RSV vaccine being tested by Pfizer is a protein-based vaccine designed to elicit an immune response that can protect against RSV infection. This vaccine has already been studied extensively in preclinical studies and phase I and II clinical trials, and it is now being tested in larger scale phase III trials involving pregnant people as well as other age groups. If successful, this RSV vaccine could be used to help reduce the incidence of RSV infections around the world and provide much needed protection for vulnerable populations such as infants and young children who are more likely to suffer from severe symptoms when infected with RSV. Furthermore, preliminary results have shown promise for this new vaccine which suggests it may be able to generate antibodies capable of preventing infection with RSV once administered at full dose during Phase III trials.

What are some additional precautionary measures to prevent RSV infection?

Respiratory Syncytial Virus (RSV) is very contagious and affects the respiratory system which can cause severe illness in infants, young children, and adults with weakened immune systems. It is especially dangerous for children younger than 6 months of age. RSV infection can lead to life-threatening complications such as inflammation of the small airways in the lung, trouble breathing, and sometimes even require mechanical ventilation or intravenous (IV) fluids. As it is currently RSV season, prevention measures are essential for protecting all individuals from this serious virus. According to the Centers for Disease Control and Prevention (CDC), prevention methods include washing hands regularly; cleaning surfaces frequently; avoiding close contact with people who have colds or other illnesses; covering coughs and sneezes with tissues or clothing items; staying hydrated; getting plenty of rest; eating healthy foods high in vitamins A & C; taking preventative medications when recommended by a doctor, especially for those at higher risk of developing more severe cases due to their age or health conditions. Taking these prevention measures seriously will help ensure everyone stays safe during this difficult time.

Respiratory syncytial virus (RSV) is a common virus that affects people of all ages, fortunately, there are treatment options available to help prevent or manage RSV infection. According to, immunoprophylaxis treatment with palivizumab (MedImmune) or nirsevimab (AstraZeneca). Palivizumab has been approved by the FDA after successful phase III trials and Nirsevimab is in the process of being FDA approved after succeeding in its phase III trials. These monoclonal antibodies offer high-risk patients an effective way to reduce their chances of contracting a severe RSV infection. Additionally, treatment may involve mechanical ventilation or intravenous fluids if needed for more serious cases. For younger children aged 6 months and under who are at highest risk of developing severe RSV infections, it is important to be vigilant during RSV season and seek medical attention as soon as any symptoms arise such as runny nose or trouble breathing. Staying hydrated will also help support your body’s natural defenses against viruses like RSV so make sure you drink plenty of water throughout the day.

Can IV hydration help with RSV?

During the RSV season, which typically occurs from November to March in most parts of the United States, young children may require mechanical ventilation or IV hydration to prevent serious illness due to RSV infection. IV hydration has become an essential part of treating RSV since it helps provide fluids directly into the bloodstream quickly and efficiently, helping keep patients hydrated while providing them with necessary nutrients. Recently approved by FDA through Phase III trials conducted by MedImmune (AstraZeneca), nirsevimab is a monoclonal antibody that provides additional protection against severe respiratory disease caused by RSV when given in combination with IV hydration and other treatments such as palivizumab (also known as Synagis). Thus IV hydration plays an important role in preventing and managing severe cases of RSV infection among infants and young children who are at high risk for developing serious illnesses related to this virus.

Fortunately, Premium Health can help RSV patients with their symptoms by providing patients with IV hydration treatment. Our IV therapies are customizable to our patients’ needs and can be provided at the time and place of your choosing. Additionally, we offer carefully tailored IV drip therapies that are designed to treat specific issues such as Jetlag, immunity boost, hair, skin and nails, etc. To learn more about Premium Health’s IV hydration treatments or to book your IV therapy appointment, visit our website or give us a call at (888)700-0750.

Related: IV Therapy & Mobile Wellness